8:22 AM
Leo Group India
| ||
| ||
| Collegium Pharmaceutical to Present at Piper Jaffray's 24th Annual Healthcare ... Sacramento Bee CUMBERLAND, R.I., Nov. 27, 2012 -- /PRNewswire/ -- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company focused on the development of innovative treatments for chronic pain, is pleased to announce it will present at Piper Jaffray's 24th ... See all stories on this topic » | ||
| Unigene and Tarix Pharmaceuticals Enter Definitive Licensing Agreement for ... Sacramento Bee According to terms of the licensing agreement, Tarix will have an exclusive worldwide license to Unigene's Peptelligence™ technology covering the use of that technology with Angiotensin (1-7), the pharmaceutical ingredient in TXA127, as well as its ... See all stories on this topic » | ||
| Pharmaceutical industry: some suggestions DAWN.com THIS is with reference to the advertisement supplement of Dawn regarding enactment of Drug Regulatory Authority of Pakistan (DRAP) Bill 2012. Nasir M. Shaikh, the Vice-Chairman of the Pakistan Pharmaceutical Merchants Association, has rightly indicated ... See all stories on this topic » | ||
| Pharmaceutical Market Fails to Capture $188B US Revenue and $564B Global ... Pharmaceutical Processing Capgemini Consulting has announced the release of its study conducted with HealthPrize Technologies, "Estimated Annual Pharmaceutical Revenue Loss Due to Medication Non-Adherence." The report provides key insights and analysis on the significant ... See all stories on this topic » | ||
| Regulus Appoints Victor Knopov, Ph.D. as Vice President, Pharmaceutical ... Sacramento Bee LA JOLLA, Calif., Nov. 27, 2012 -- /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ:RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the appointment of Victor ... See all stories on this topic » | ||
| Sucampo Pharma, Abbott launch Amitiza in Japan to treat chronic constipation pharmabiz.com Sucampo Pharmaceuticals, Inc. (SPI), a global pharmaceutical company, and Abbott have introduced Amitiza (lubiprostone) in Japan, a prescription medicine for the treatment of chronic constipation not caused by organic diseases. Amitiza was approved by ... See all stories on this topic » | ||
| Transcept Pharmaceuticals to Host Conference Call to Discuss Broadened ... Sacramento Bee POINT RICHMOND, Calif., Nov. 26, 2012 -- /PRNewswire/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic ... See all stories on this topic » | ||
| Govt told SC: Need 2 more weeks to notify drug pricing policy Business Standard The Department of Pharmaceuticals (DoP) is likely to notify the National Pharmaceutical Pricing Policy (NPPP) in around two weeks, it informed the Supreme Court (SC) on Tuesday. The apex court, which has been creating pressure on the government to fast ... See all stories on this topic » | ||
| SANTEN PHARMACEUTICAL CO., LTD. : Intravitreal VEGF Inhibitor "EYLEA ... 4-traders Osaka, November 27, 2012 - Bayer Yakuhin, Ltd. (Osaka, hereafter Bayer Yakuhin) and Santen Pharmaceutical Co., Ltd. (Osaka, hereafter Santen) today launched the intravitreal VEGF* inhibitor "EYLEA® solution for intravitreal injection 40 mg/mL" ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment